Dutch entertainer Gordon reveals his remarkable three-year journey of weight loss, improved mental health, and diabetes remission on the cover of Men’s Health, inspiring others to start over regardless of age. Gordon appears on the cover of Men’s Health this…
A large French study suggests a sugar molecule found mainly in red meat may be associated with a higher risk of developing type 2 diabetes, although causality has yet to be established. A large French study has added to evidence…
Zag Bio has launched its first human study of ZAG-101, an innovative therapy aiming to modify the disease process in type 1 diabetes by targeting the immune system through the thymus, marking its transition into clinical-stage development. Zag Bio said…
A new weekly diabetes meal plan emphasises flexibility and practical routines over rigid diets, offering personalised support for better blood sugar management. A weekly diabetes meal plan published by Diabetes Meal Plans is built around lower-carbohydrate dishes, leftovers and a…
Utah regulators have approved August AI to pilot a supervised AI-assisted system for renewing prescriptions for chronic conditions, marking a significant step in integrating AI into medical administration with physician oversight. August AI has received approval from Utah regulators to…
Breakthrough T1D announces its inaugural clinical and research congress in Philadelphia, uniting global experts to advance treatments and move closer to a cure for type 1 diabetes. Breakthrough T1D has announced an inaugural clinical and research congress that it says…
Four girls from interconnected Palestinian families carrying identical WFS1 mutations exhibit a wide spectrum of disease severity, emphasising the unpredictable nature of Wolfram syndrome despite genetic similarities. Four girls from two closely linked Palestinian families have given doctors a rare…
VTV Therapeutics has finished enrolling 166 participants in its phase 3 CATT1 study of cadisegliatin, an experimental oral drug aimed at reducing hypoglycaemia and improving glucose control in adults with type 1 diabetes, with topline results expected by mid-2027. vTv…
Rezolute reports that the US Food and Drug Administration has suggested a pre-BLA meeting for ersodetug, following a mixed Phase 3 trial in congenital hyperinsulinism, as the company prepares for potential approval in a high-need rare disease area. Rezolute said…
New research from MiniMed indicates that users who respond more frequently to alerts from its Smart MDI system experience significant improvements in glucose control, highlighting the importance of timely prompts in diabetes care. MiniMed said new trial data suggest that…
